ACHIEVEMENTS

1999
Biological Targets, Inc. was formed as a Delaware corporation. The Company began its R&D activities in temporary laboratories located at the campus of The University of Texas at Dallas.

2000
Biological Targets, Inc. developed its diverse intellectual property portfolio that is The Company’s primary differentiator. The Company filed its first patent applications to protect its product development and technology platforms.

2001-2003
Biological Targets, Inc. finalized its strategic business plan and expanded its financial base by obtaining first-round private funding. The Company developed its technology application platforms, SPADE™ and DELVE™, for integrating bioinformatics, functional genomics and high-throughput gene screening.

2004
Biological Targets, Inc. moved into its new facilities, 7,000 square feet of modern laboratory and office space located in the Bio-Labs Building situated in the center of Dallas’ biotechnology community.

2005
Biological Targets, Inc. established its R&D programs with primary emphasis on four main areas:
• Molecular targets for insecticide development
• Bt-based biopesticides
• Products for soil improvement
• Anti-microbials for disease control

2006
Biological Targets, Inc. developed InsectaCLONE™ gene libraries and expression arrays for target identification and insecticide chemistry screening using its discovery platform dSCOVA™. The Company introduced MosquitOME™ Expression Panel for target-directed screening of insecticidal compound in cell-base assays.

Biological Targets, Inc. also introduced RECLAFIL™, 100% organic product for soil improvement and erosion control applications. The Company premiered RECLAFIL™ at the International Erosion Control Association's Trade Show and Annual Meeting in Long Beach (CA) February 20-24, 2006.